Vanilloid Receptor 1 Agonists, Capsaicin and Resiniferatoxin, Enhance MHC Class I-restricted Viral Antigen Presentation in Virus-infected Dendritic Cells
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
DCs, like the sensory neurons, express vanilloid receptor 1 (VR1). Here we demonstrate that the VR1 agonists, capsaicin (CP) and resiniferatoxin (RTX), enhance antiviral CTL responses by increasing MHC class I-restricted viral antigen presentation in dendritic cells (DCs). Bone marrow-derived DCs (BM-DCs) were infected with a recombinant vaccinia virus (VV) expressing OVA (VV-OVA), and then treated with CP or RTX. Both CP and RTX increased MHC class I-restricted presentation of virus-encoded endogenous OVA in BM-DCs. Oral administration of CP or RTX significantly increased MHC class I-restricted OVA presentation by splenic and lymph node DCs in VV-OVA-infected mice, as assessed by directly measuring OVA peptide SIINFEKL-Kb complexes on the cell surface and by performing functional assays using OVA-specific CD8 T cells. Accordingly, oral administration of CP or RTX elicited potent OVA-specific CTL activity in VV-OVA-infected mice. The results from this study demonstrate that VR1 agonists enhance anti-viral CTL responses, as well as a neuro-immune connection in anti-viral immune responses.
Abstract
DCs, like the sensory neurons, express vanilloid receptor 1 (VR1). Here we demonstrate that the VR1 agonists, capsaicin (CP) and resiniferatoxin (RTX), enhance antiviral CTL responses by increasing MHC class I-restricted viral antigen presentation in dendritic cells (DCs). Bone marrow-derived DCs (BM-DCs) were infected with a recombinant vaccinia virus (VV) expressing OVA (VV-OVA), and then treated with CP or RTX. Both CP and RTX increased MHC class I-restricted presentation of virus-encoded endogenous OVA in BM-DCs. Oral administration of CP or RTX significantly increased MHC class I-restricted OVA presentation by splenic and lymph node DCs in VV-OVA-infected mice, as assessed by directly measuring OVA peptide SIINFEKL-Kb complexes on the cell surface and by performing functional assays using OVA-specific CD8 T cells. Accordingly, oral administration of CP or RTX elicited potent OVA-specific CTL activity in VV-OVA-infected mice. The results from this study demonstrate that VR1 agonists enhance anti-viral CTL responses, as well as a neuro-immune connection in anti-viral immune responses.
참고문헌 (29)
- Caterina, M. J, "The capsaicin receptor: a heat-activated ion channel in the pain pathway", Nature, 389, pp.816~824 (1997)
- Szallasi, A, "Vanilloid (Capsaicin)receptors and mechanisms", Pharmacol. Rev, 51, pp.159~212 (1999)
- Szallasi, A, "The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept", Nat. Rev. Drug Discov, 6, pp.357~372 (2007)
- Everaerts, W, "The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil", Curr. Biol, 21, pp.316~321 (2011)
- Holzer, P, "Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons", Pharmacol. Rev, 43, pp.143~201 (1991)
- Szallasi, A, "Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper", Neuroscience, 30, pp.515~520 (1989)
- Bley, K. R, "Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies", Expert Opin. Investig. Drugs, 13, pp.1445~1456 (2004)
- Nilsson, G, "Altered lymphocyte proliferation of immunized rats after neurological manipulation with capsaicin", Int. J. Immunopharmacol, 10, pp.747~751 (1988)
- Gertsch, J, "Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds", Pharm. Res, 19, pp.1236~1243 (2002)
- Kim, C. S, "Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages", Cell. Signal, 15, pp.299~306 (2003)
- Chen, C. W, "Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages", Br. J. Pharmacol, 140, pp.1077~1087 (2003)
- Santoni, G, "Impairment of rat thymocyte differentiation and functions by neonatal capsaicin treatment is associated with induction of apoptosis", J. Neuroimmunol, 104, pp.37~46 (2000)
- Kradin, R, "Pulmonary response to inhaled antigen: neuroimmune interactions promote the recruitment of dendritic cells to the lung and the cellular immune response to inhaled antigen", Am. J. Pathol, 150, pp.1735~1743 (1997)
- Basu, S, "Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells", Proc. Natl. Acad. Sci. U.S.A, 102, pp.5120~5125 (2005)
- Nevius, E, "Oral ingestion of capsaicin, the pungent component of chili pepper, enhances a discreet population of macrophages and confers protection from autoimmune diabetes", Mucosal Immunol, 5, pp.76~86 (2012)
- Mahmoud, M. E, "Capsaicin inhibits IFN-gamma-induced MHC class II expression by suppressing transcription of class II transactivator gene in murine peritoneal macrophages", Int. Immunopharmacol, 10, pp.86~90 (2010)
- Karttunen, J, "Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens", Proc. Natl. Acad. Sci. U. S. A, 89, pp.6020~6024 (1992)
- Harding, C. V, "Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules", J. Immunol, 153, pp.4925~4933 (1994)
- Harding, C. V, "Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation", J. Immunol, 147, pp.2860~2863 (1991)
- Porgador, A, "Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody", Immunity, 6, pp.715~726 (1997)
- Lee, Y. R, "Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells", Blood, 105, pp.3951~3955 (2005)
- Lee, Y. H, "Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells", Int. Immunopharmacol, 11, pp.985~991 (2011)
- Lee, Y. H, "Calcineurin inhibitors block MHC-restricted antigen presentation in vivo", J. Immunol, 179, pp.5711~5716 (2007)
- Park, C. S, "Identification of HLA-A2-restricted immunogenic peptides derived from a xenogenic porcine major histocompatibility complex", Xenotransplantation, 21, pp.465~472 (2014)
- Nilsson, G, "Effects on immune responses in the rats after neuromanipulation with capsaicin", Int. Immunopharmacol, 13, pp.21~26 (1991)
- Guermonprez, P, "Antigen presentation and T cell stimulation by dendritic cells", Annu. Rev. Immunol, 20, pp.621~667 (2002)
- Bevan, M. J, "Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay", J. Exp. Med, 143, pp.1283~1288 (1976)
- Harding, C. V, "Phagocytic processing of antigens for presentation by MHC molecules", Trend. Cell. Biol, 5, pp.105~108 (1995)
- Heath, W. R, "Cross-presentation in viral immunity and self-tolerance", Nat. Rev. Immunol, 1, pp.126~134 (2001)